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Summary: This first detailed report of a female patient with functional methionine
synthase deficiency due to the cblE defect describes treatment with several vitamins
and cofactors and clinical progress for 17 years. Before treatment, major findings
we re micro c ep h a ly, psychomotor re t a rd ation, episodic reduced consciousness,
megaloblastic anaemia, increased plasma free homocystine (>20µmol/L), low
plasma methionine (<10µmol/L) and increased excretion of formiminoglutamate.
On high-dose folic acid, biochemical abnormalities such as formiminoglutamate
excretion and homocystinuria nearly normalized, but clinical and haematological
abnormalities remained. On replacement of folate with methylcobalamin, alertness,
motor function, speech and the electro e n c ep h a l ogram improve d, bioch e m i c a l
features were similar, but the mean corpuscular volume increased. The best control
was observed on a combination of folate and methylcobalamin. At 17 years of age
she remains severely mentally retarded.
In cultured fibroblasts methionine synthesis was reduced (0.03nmol/mg/per 16h,
controls 2.4–6.9); methionine synthase activity was normal under high reducing
conditions but decreased on limiting the reducing agent, dithiothreitol, to 5 mmol/L
(18% of total, controls 51–81%); formation of methylcobalamin was low (4.5% of
total cobalamins, control 57.5%) and complementation studies indicated the cblE
defect. Methionine formation showed only minor increases in cells grown in folate-
or cobalamin-supplemented medium. Serine synthesis, which was low in normal
medium, increased with cobalamin supplementation. These studies suggest further
heterogeneity within cblE mutants, show the difficulty of establishing the enzyme
defect in vitro, and indicate a role for folate in addition to cobalamin in treatment.
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In man there are two known reactions wh i ch re q u i re vitamin B1 2 (cobalamin; cbl) cofa c t o rs
for activ i t y. One is adenosylcobalamin (Adocbl ) - d ependent methy l m a l o nyl-CoA mu t a s e
(EC 5.4.99.2), wh i ch cat a lyses the conve rsion of methy l m a l o nyl-CoA to succinyl-CoA. Th e
other is methylcobalamin (Mecbl ) - d ependent 5-methy l t e t ra hy d ro fo l at e : h o m o cy s t e i n e
m e t hy l t ra n s fe rase (methionine synthase, EC 2.1.1.13), wh i ch conve rts homocysteine to
methionine (Fenton and Rosenberg 1995). These coenzymes are fo rmed from their vitamin
p re c u rsor hy d roxocobalamin by a complex sequence of processes (Fi g u re 1). Adocbl is
fo rmed from hy d roxocobalamin intra m i t o ch o n d ri a l ly by successive reductions of the cobalt
atom fo l l owed by adenosyl group tra n s fe r. Defects of Adocbl fo rm ation, cblA (McKu s i ck
251100) and cblB (McKu s i ck 251110), result in methylmalonic aciduria. Mecbl is fo rm e d
f rom hy d roxocobalamin in the cytoplasm by the cat a lytic action of methionine synthase.
This enzyme is crucial for proper re cy cling of fo l ate and its coenzymes and thereby
p rovides an important link between cobalamin and fo l ate metabolism. Defects of steps in
cobalamin processing wh i ch are common to both coenzymes result in combined
h o m o cy s t i nu ria and methylmalonic aciduria, designated on the basis of ge n e t i c
c o m p l e m e n t ation analysis as cblC (McKu s i ck 277400), cblD (McKu s i ck 277410) and cbl F
( M c Ku s i ck 277380). Homocy s t i nu ria associated with altered methionine synthase activ i t y
and deficient Mecbl synthesis but normal Adocbl fo rm ation has been found in patients with
either the cblE (McKu s i ck 236270) or cblG (McKu s i ck 250940) defect. In the 12 pat i e n t s
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Figure 1 Intracellular processing of cobalamins. The main steps in the pathway are summarized.
The numbers indicate the sites of genetic defects as follows: (1) cblF; (2) cblC/D (exact site not
known); (3) cblE/G; (4) cblA; (5) cblB
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rev i ewed in detail (Watkins and Rosenbl att 1989; Hall 1990) anaemia, mega l o bl a s t o s i s ,
mental re t a rd ation and neuro l ogical ab n o rmalities we re common findings. All patients have
s h own va rying degrees of biochemical and clinical response to tre atment with cobalamin.
The effect of fo l ate or folinic acid on the biochemical and clinical outcome is unclear since
t h ey have been used mainly in combined tre atments. Howeve r, in one cblE patient no effe c t
was rep o rted (Schuh et al 1984) while in a cblG patient some benefit was seen (Shin et al
1986). So far 5 males with the cblE defect have been described (Schuh et al 1984;
R o s e n bl att et al 1985; Tu chman et al 1988) but two females are known anecdotally (Fe n t o n
and Rosenberg 1995). Much clinical and biochemical heterogeneity is evident among cbl E
and cblG patients. In this paper we describe a female patient with deficient methionine
synthesis in cultured fib ro blasts due to the cblE defect who shows clinical and bioch e m i c a l
d i ffe rences from prev i o u s ly rep o rted cblE patients. The response of amino acid levels and
h a e m at o l ogical ab n o rmalities to tre atment with va rious cofa c t o rs in vivo c o m p a red with
re s p o n s iveness of methionine synthesis and serine fo rm ation in cultured fib ro blasts and the
l o n g - t e rm clinical outcome are rep o rt e d.
M ATERIALS AND METHODS
Vitamin B1 2 ( G i j zen et al 1983) and vitamin B6 ( A n d e rson et al 1970) we re measure d
m i c ro b i o l ogi c a l ly and fo l ate was determined as described by Vo ogd (Vo ogd et al 1985).
Fo rm i m i n oglutamic acid was determined (Tabor and Wi j n ga rden 1958) and L- h i s t i d i n e
loading was perfo rmed (Niederwieser et al 1974) as descri b e d. Blood concentrations of
cobalamins we re measured as rep o rted (van Kapel et al 1983). Plasma and urine amino
acids including free homocystine we re measured after dep ro t e i n i z ation (sulphosalicy l i c
acid) using a Beckman 121M amino acid analy s e r. Uri n a ry organic acids we re analy s e d
ga s - ch ro m at ograp h i c a l ly as tri m e t hy l s i lyl derivat ives essentially as prev i o u s ly descri b e d
( D u ran et al 1978). Skin fib ro blasts we re grown in Eag l e ’s minimum essential medium
containing undialysed fetal calf serum (10% v/v), nonessential amino acids (1% w/v) and
k a n a mycin (100mg/L). Cell cultures we re peri o d i c a l ly tested to ex clude my c o p l a s m a
c o n t a m i n ation. Confluent cultures we re harvested using trypsin (0.25% w/v) then stored at
–70°C prior to assay s .
D i hy d ro fo l ate reductase (Mukulu et al 1973) and glutamate fo rm i m i n o t ra n s fe ra s e
(Niederwieser et al 1974) we re measured in liver (needle biopsy) as rep o rt e d. Methy-
l e n e t e t ra hy d ro fo l ate reductase activity was assayed both in liver and in cultured fib ro bl a s t s
as described (Rosenbl att and Erbe 1977). Cystathionine β-synthase was assayed in culture d
fib ro blasts as prev i o u s ly described (Fowler et al 1978). Methionine synthase was assayed in
c u l t u red fib ro blasts as described by Mellman (Mellman et al 1978). All enzyme activ i t i e s
we re re l ated to protein determined by the Low ry method (Low ry et al 1951).
I n c o rp o ration of label from [1 4C ] p ro p i o n ate into protein was assayed in intact fib ro bl a s t
m o n o l ayer cultures (Wi l l a rd et al 1976). Methionine fo rm ation from homocysteine wa s
d e t e rmined in fib ro blast monolayer cultures as prev i o u s ly described (Fowler 1982) ex c ep t
t h at in some ex p e riments [14C ] fo rm ate was used as the labelled pre c u rsor in place of
[3 5S ] h o m o cysteine (Boss 1985). In these ex p e riments cells we re incubated with 5ml of
E a rl e ’s basic salt solution wh i ch contained [1 4C ] fo rm ate (2µCi/ml), sodium fo rm at e
( 2 5 0µmol/L) and L- h o m o cysteine (200µmol/L) prep a red fre s h ly from its thiolactone
Functional methionine synthase deficiency 733
J. Inher. Metab. Dis. 20 (1997)
jimd 2926  21/10/1997 13:26  Page 733
( Fowler et al 1978). This modific ation allowed simultaneous measurement of methionine
and serine fo rm ation. In some ex p e riments cells we re grown in normal medium for 4 day s
fo l l owed by growth for 3 days in medium supplemented with va rious cofa c t o rs .
C o m p l e m e n t ation studies we re perfo rmed as prev i o u s ly described (Watkins and
R o s e n bl att 1988). Synthesis of cobalamin coenzymes from [5 7C o ] cyanocobalamin wa s
m e a s u red in cultured fib ro blasts as prev i o u s ly described (Rosenbl att et al 1984).
All ra d i o chemicals we re obtained from Amersham Intern ational. Tissue culture mat e ri a l s
we re purchased from Gibco Europe and all other chemicals we re of the highest puri t y
c o m m e rc i a l ly ava i l abl e.
Patient history : The patient was the first child born to healthy parents after a norm a l
p reg n a n cy and delive ry. Th e re we re no earlier pregnancies. The birth weight was 3090g,
length was 51cm and head circ u m fe rence was normal. A sibling born later has deve l o p e d
n o rm a l ly. The patient first presented at 6 months of age with feeding pro blems, with we i g h t
falling from the 25th centile at 6 weeks to below the 10th centile at 6 months. Bilat e ra l
cl i n o d a c t y ly and bilat e ral syndactyly we re present. Th e re was micro c ep h a ly (head
c i rc u m fe rence below the 5th centile), but no neuro d evelopmental ab n o rmalities we re
o b s e rve d. Marked anaemia (haemoglobin (Hb) 5.1mmol/L, haemat o c rit (Ht) 0.24, mean
c o rpuscular volume (MCV) 122fl) was found wh i ch was unre s p o n s ive to iron tre atment and
was shown to be mega l o blastic by bone marrow and blood smear ex a m i n at i o n .
At the age of 14 months the patient had a limited ability to walk and speak, but this wa s
p rogre s s ive ly lost starting at about 16 months of age. At this age, periods of lowe re d
consciousness with staring and long sleeping periods during the day we re observe d. At 21
months of age she was unable to sit or stand, her upper limbs we re hypotonic and her leg s
we re hy p e rt o n i c, indicating that regression had occurre d. During the second year of life the
head circ u m fe rence decreased to below the 3rd centile, weight remained below the 10th
centile and height at the 25th centile. When she was seen at 22 months, anaemia was still
evident (Hb 5.5mmol/L, Ht 0.28, MCV 132fl). The electro e n c ep h a l ogram showed under-
d eveloped diffe re n t i ation and diffuse irreg u l a rities but no ep i l eptic ab n o rmalities, and a
computer tomograp hy scan revealed a limited diffuse widening of the ve n t ricular system.
At 2 ye a rs of age, screening for metabolic disord e rs revealed ex c e s s ive ex c retion of
h o m o cy s t i n e, sulphite and fo rm i m i n oglutamic acid. In plasma, free homocy s t i n e
c o n c e n t ration was increased (20µmol/L, normal not detectable) with low methionine
c o n c e n t ration (10µmol/L, normal 28–40). In addition, fo rm i m i n oglutamic acid ex c re t i o n
was elevated on seve ral occasions, ra n ging from 30 to 190µmol/mmol cre atinine (norm a l
0–15). Plasma concentrations of vitamin B1 2 ( 4 4 6pmol/L), fo l ate (34nmol/L) and vitamin
B6 ( 5 9nmol/L) we re normal. Fo l ate concentration (50nmol/L) was also normal in
c e reb rospinal flu i d. Uri n a ry organic acids we re normal with no increase of methy l m a l o n i c
a c i d. The Schilling test showed normal vitamin B1 2 ab s o rption. Normal concentration of
t ranscobalamins I, II and III and unsat u rated B1 2 binding capacity we re fo u n d, prov i d i n g
f u rther evidence of normal vitamin B1 2 u p t a ke (assays perfo rmed by Dr V. Herbert ,
H a e m at o l ogy and Nutrition Lab o rat o ry, Ve t e rans Administration Hospital, Bronx, New
Yo rk, USA). The prev i o u s ly observed haemat o l ogical ab n o rmalities pers i s t e d, with
s eve re ly mega l o blastic bone marrow containing a high number of cells, hy p e rs eg m e n t at i o n
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and ab n o rmal cell divisions (mega l o blastic cells 20%; norm o blasts 4.5%; poly ch ro m at i c
e ry t h ro blasts 6.25%).
D u ring the fo l l owing ye a rs va rious tre atments we re tried in attempts to correct the
h a e m at o l ogical, biochemical and clinical ab n o rmalities (see Table 1 and below). Tre at m e n t
with fo l ate (40m g / d ay, oral) from 2 to 7 ye a rs of age resulted in the fo l l owing ch a n ge s
c o m p a red with the immediate pre t re atment values. Plasma methionine increased from 10 to
2 6µmol/L; plasma and urine homocystine fell from 10µmol/L to undetectable and from 40
to 10µm o l / 2 4h, re s p e c t ive ly; Hb increased from 5.1 to 7.8mmol/L and the MCV fell fro m
132 to 110fl. Fo rm i m i n oglutamic acid ex c retion after histidine loading was mu ch lower at
980 and 260µm o l / 2 4h (normal 0–12) compared with 2980µm o l / 2 4h befo re tre at m e n t .
At the age of 3 ye a rs, hy d roxocobalamin (1mg i.m. 2 we e k ly) was added for a period of only
2 months. This was discontinued since no additional positive effect on the MCV was fo u n d.
In spite of the biochemical and haemat o l ogical response to fo l at e, poor growth continu e d
and mental re t a rd ation, hy p e rre flexia and spasticity re m a i n e d. During this period seve ra l
episodes of reduced consciousness necessitated admissions to hospital. At 6.5 ye a rs of age,
the electro e n c ep h a l ogram showed a ge n e ra l i zed fo rm of ep i l epsy wh i ch was tre ated with
va l p roic acid. Also, bone marrow ex a m i n ations rep e at e d ly showed mega l o bl a s t i c
ch a ra c t e ristics. At 7 ye a rs of age the computed tomograp hy scan again showed slightly
e n l a rged ve n t ri cles. At this time the serum concentration of Mecbl was found to be low
( 2 1pmol/L = 4% of total; controls (n=15) 182 ± 50pmol/L = 46.9%).
From the age of 7 ye a rs 2 months she was tre ated for 1 year with Mecbl (Algobaz, 1.0m g
i.m. monthly) combined with fo l ate (40m g / d ay) resulting in good control of plasma and
u rine homocystine concentrations and reduced mega l o blastic ch a n ges (MCV 104– 1 1 0 ) .
After 6 months on this tre atment there was a clear clinical improvement indicated by better
consciousness and reduced daytime sleep i n g, and some improvement of motor function and
s p e e ch .
From 8 ye a rs 2 months to 13 ye a rs of age, tre atment was with Mecbl alone, with MCV
values of 115–118. At 12.5 ye a rs of age, weight and length we re at the 25th centile bu t
m i c ro c ep h a ly remained with the head circ u m fe rence below the 3rd centile. At 13 ye a rs of age,
some clinical deteri o ration was observed with lowe red consciousness, and daytime sleep i n g
was observed together with further loss of motor function and speech. Fo l ate tre at m e n t
( 4 0m g / d ay) was then re i n t roduced in combination with Mecbl (1.0mg i.m. monthly, see Tabl e
1) with a fall in the MCV value; while plasma and urine homocystine remained undetectabl e,
plasma methionine was 20 µmol/L, and Hb 7.45– 7 . 9 5mmol/L. Short ly afterwa rds she
became more alert during the day, suggesting an additional effect of fo l at e.
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Table 1 Main tre atment modalities in the pat i e n t
Age (years) Specific treatment MCV (fl)
0 –2 None 122–132
2–7 Folate (40mg/day, oral) 108–114
7– 8 Folate (40mg/day, oral) + methylcobalamin (1mg i.m., monthly) 104–110
8 –13 Methylcobalamin (1mg i.m., monthly) 115–118
13–17 Methylcobalamin (1mg i.m., monthly) + folate (40mg/day, oral) 100–109
jimd 2926  21/10/1997 13:26  Page 735
At 17 ye a rs of age, no further ch a n ge in her clinical state was observe d. Psych o l ogi c a l
assessment in this micro c ephalic juvenile showed function at the 3.5-year leve l .
R E S U LT S
Enzyme studies: S eve ral enzymes we re assayed in either a needle liver biopsy or culture d
skin fib ro blasts (Table 2). The activities of dihy d ro fo l ate reductase (liver), methy l e n e t e t ra -
hy d ro fo l ate reductase (liver and cultured fib ro blasts), glutamate fo rm i m i n o t ra n s fe ra s e
( l iver) and cy s t athionine β-synthase (cultured fib ro blasts) we re all within the control ra n ge s .
Studies in intact fib ro bl a s t s I n c o rp o ration of label from [1 4C ] p ro p i o n ate into tri ch l o ro a c e t i c
a c i d - p re c i p i t able protein was normal (9.8nmol/mg per 16h: controls (n=29) 4.2–19.6). In
c o n t rast, labelled methionine fo rm ation from homocysteine in cells grown in unsupplemented
medium was marke d ly deficient using both [3 5S ] h o m o cysteine (0.09–0 . 2 1nmol/mg per 16h ,
mean 0.15; controls (n=24) 4.5–14.1, mean 7.4) and [1 4C ] fo rm ate (0.01–0 . 0 5nmol/mg per
1 6h, mean 0.03; controls (n=19) 2.4–6.9, mean 3.6) as the labelled pre c u rs o r. Clearly re d u c e d
fo rm ation of labelled serine from [1 4C ] fo rm ate label was also found (0.54– 1 . 8 5nmol/mg per
1 6h, mean 0.86; controls (n=16) 2.8–10.3, mean 5.5). Th e re was no ap p re c i able increase of
l abelled methionine or serine fo rm ation in patient cells grown in media supplemented with the
fo l l ow i n g : (1) fo l ate (up to 200mg/L); (2) folinic acid (40mg/L); (3) methy l t e t ra hy d ro fo l at e
(up to 200mg/L); (4) fo l ate and methylcobalamin in combination (200mg/L and 1m g / L ,
re s p e c t ive ly); (5) methy l t e t ra hy d ro fo l ate and methylcobalamin in combination (200mg/L and
1mg/L, re s p e c t ive ly ) .
L abelled serine fo rm ation increased from 0.86 in normal medium to 1.05 and
1 . 2nmol/mg per 16h in medium supplemented with 1 or 10mg/L of hy d rox o c o b a l a m i n ,
re s p e c t ive ly (19% and 21% of the mean control value), while the fo rm ation of methionine
i n c reased from 0.03 to 0.08 and 0.09nmol/mg per 16h, re s p e c t ive ly. Howeve r, these
i n c reased methionine values rep resent only 2–2.5% of the mean control va l u e.
C o rresponding values for medium supplemented with the same concentrations of
m e t hylcobalamin we re 0.024 (1mg/L) and 0.06 nmol/mg per 16h (10mg/L) for methionine
fo rm ation, and 0.72 and 0.95nmol/mg per 16h for serine synthesis.
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Table 2 Enzymes of fo l ate and homocysteine metabolism: activities in liver and skin fib ro bl a s t s
Enzyme Tissue Patient Controls
Dihydrofolate reductase Liver 4.6, 4.3 3.8–5.4 (n=3)
(nmol/min per mg protein)
Glutamate formiminotransferase Liver 1350 854
(nmol/min per mg protein)
Methylene THF reductasea Liver 5.5, 5.2 4.4– 6.4 (n=4)
(nmol/h per mg protein)
Methylene THF reductase Fibroblasts 5.1 3.7–16 (n=32)
(nmol/h per mg protein)
Cystathionine β-synthase Fibroblasts–PLP 8.1 3.6–25.7 (n=29)
(nmol/h per mg protein) +PLP 10.2 4.9–32 (n=29)
a THF, tetrahydrofolate
b PLP, pyridoxal 5′-phosphate
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Finally it should be noted that no decrease of serine formation was observed in control
or patient cells supplemented with methy l e t e t ra hy d ro fo l ate compared with
unsupplemented medium.
Methionine synthase (MS) activity in cultured fib ro bl a s t s : When MS was assayed with
s t rong reducing conditions (150mmol/L β- m e rc aptoethanol), activity in patient fib ro bl a s t s
was within or a little below the control ra n ge (Table 3). The diffe rent values re flect the
k n own va ri ability of this assay. Holoenzyme activity measured in the absence of add e d
c o e n z y m e, methylcobalamin, was not re d u c e d. Import a n t ly, in two ex p e riments activity in
the presence of 5mmol/L dithiothreitol as the added thiol, ex p ressed as a perc e n t age of the
a c t ivity with β- m e rc aptoethanol, was signific a n t ly lower in the patient cell ex t racts than in
c o n t rols (18% and 19% of the activity with β- m e rc aptoethanol compared with 83%, 51%,
80% and 69% in contro l s ) .
C o m p l e m e n t ation studies: The uptake of ra d i o a c t ivity from [1 4C ] m e t hy l t e t ra hy d ro fo l at e
into protein was measured in the patient fib ro blasts fused with cells known to belong to
either the cblE or cblG mu t ation class. In the patient cells mixed with cblE cells uptake wa s
55 and 52p m o l / 1 8h per mg protein in the absence (unfused) and in the presence (fused) of
p o lye t hylene glycol, re s p e c t ive ly. In contrast, in cells mixed wtih two cblG cell lines, uptake
of label was 56p m o l / 1 8h per mg protein unfused ve rsus 108 fused, and 50 unfused ve rs u s
80 fused. These are 93% and 50% increases, indicating complementation with the cbl G
cells but not with the cblE cells.
Cobalamin coenzymes in blood and cultured fib ro bl a s t s : The pro p o rtion of the methy l
fo rm in blood was cl e a rly re d u c e d, with normal amounts of adenosylcobalamin without
t re atment (see ab ove). The synthesis of cobalamin coenzymes measured in culture d
fib ro blasts is shown in Table 4. The fo rm ation of methylcobalamin was mu ch lower in the
p atient cells than in a simu l t a n e o u s ly studied control cell line, although the total cobalamin
u p t a ke was similar.
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Table 3 Methionine synthase activity in fib ro blasts (pmol/min per mg pro t e i n )a
Conditions Complete Complete No added
150mmol/L BMEb 150mmol/L BME thiol 5mmol/L DTTd 25mmol/L DTT
+ Mecblc – Mecbl + Mecbl + Mecbl + Mecbl
Control 1 110 41 (37) 3 (3) 91 (83) 102 (92)
Control 2 95 49 (51)
Control 3 105 84 (80)
Control 4 112 77 (69)
Control rangee 58–150
Patient 105 (100) 58 (55) 2 (2) 20 (19) 72 (68)
Patient repeat 51 (100) 9 (18)
a The values in parentheses are the percentage of the activity in the complete assay with added Mecbl
b BME, β-mercaptoethanol
c Mecbl, methylcobalamin 50 µmol/L
d DTT, dithiothreitol
e Range of activity in the complete assay obtained with controls 1–4 plus 6 additional control cell lines
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D I S C U S S I O N
Th e re is concl u s ive evidence for a disorder of methionine synthase function in this pat i e n t .
Fi rst, increased blood and urine concentrations of homocystine with low blood levels of
methionine we re present together with normal methy l e n e t e t ra hy d ro fo l ate reductase activ i t y
in liver and fib ro blasts. Second, synthesis of methionine from either labelled homocy s t e i n e
or labelled fo rm ate in fib ro blasts was re d u c e d, indicating defe c t ive re m e t hy l ation of
h o m o cy s t e i n e. Th e re was no methylmalonic aciduria in this ch i l d, together with norm a l
u p t a ke of labelled pro p i o n ate into protein in fib ro blasts, indicating normal methy l m a l o ny l -
CoA mu t a s e - d ependent conve rsion of pro p i o n ate to succinat e. This rules out a combined
d e fect due to ab n o rmal cytosolic or lysosomal cobalamin processing (cblC, cblD or cbl F
d e fect). Th i rd, methionine synthase activity was deficient in cultured fib ro blasts wh e n
a s s ayed under low reducing conditions, as rep o rted for other patients with the cblE defe c t
( R o s e n bl att et al 1984). Fo u rth, methylcobalamin levels we re reduced in blood and in
c u l t u red fib ro blasts. Fi n a l ly, complementation studies confirmed the cblE defe c t .
S eve ral fe at u res in this patient can be explained by the methyl trap hypothesis as
p roposed in a patient with combined homocy s t i nu ria and methylmalonic aciduri a
( B a u m ga rtner et al 1985) and also implicated in vitamin B1 2 d e fic i e n cy (Higginbottom et al
1978). In this hypothesis, lack of tra n s fer of the methyl group of 5-methy l fo l ate to
h o m o cysteine by methionine synthase causes an irreve rs i ble accumu l ation of the 5-methy l
fo rm of tetra hy d ro fo l at e, leading to a lack of other essential fo rms of fo l ate coenzymes
( C h a n a rin et al 1989). For ex a m p l e, mega l o blastic anaemia can be due to reduced levels of
fo l ate compounds re q u i red for DNA synthesis. Also, further metabolism of
fo rm i m i n oglutamic acid wh ch is fo rmed in the cat abolism of histidine depends on the
a c t ivity of two fo l ate enzymes, glutamate fo rm i m i n o t ra n s fe rase and fo rm i m i n o -
t e t ra hy d ro fo l ate cy cl o d e a m i n a s e. Thus functional defic i e n cy of fo l ate coenzymes could
lead to the marked increase of uri n a ry fo rm i m i n oglutamic acid ex c retion seen in our pat i e n t .
H oweve r, this was not described in other cblE patients and was found in only one cbl G
p atient (Shin et al 1986). This compound was ap p a re n t ly not measured in other patients and
it is unclear whether this is a consistent fe at u re of this disord e r.
Reduced fo rm ation of labelled serine from [1 4C ] fo rm ate in cultured fi b ro bl a s t s
p re s u m ably re flects reduced activity of the 5,10-methy l e n e t e t ra hy d ro fo l at e - d ep e n d e n t
s e rine hy d rox y m e t hy l t ra n s fe rase (Strong and Sch i rch, 1989), possibly due to re s t ri c t e d
ava i l ability of this fo l ate coenzyme. Inhibition of serine hy d rox y m e t hyl tra n s fe rase by 5-
m e t hy l t e t ra hy d ro fo l ate (Strong and Sch i rch 1989) seems unlike ly to be the ex p l a n ation of
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Table 4 Fo rm ation of cobalamins in cultured fib ro bl a s t s
Cobalamin uptake (per 106 cells) Cobalamin distribution (% of total)
(cpm) (pg) Aqa CNb Adenosyl Methyl Other
Control 2443 7 2.5 12 19 57.5 9
2422 7
Patient 4397 11.7 9 28 29.5 4.5 29
4271 11.4
a Aq, aquacobalamin,
b CN, cyanocobalamin
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l ow serine fo rm ation since we found no lowe ring of serine fo rm ation in the presence of ve ry
high concentrations of this fo l ate coenzyme in patient or control cells. Defe c t ive seri n e
fo rm ation has also been observed in fib ro blasts of patients with combined homocy s t i nu ri a /
m e t hylmalonic aciduria, in wh i ch there is low methionine synthase activity and defe c t ive
m e t hylcobalamin synthesis (cblC/D mutants) (Fowler et al 1997). Such a deficient activ i t y
is unlike ly to influence in vivo l evels of serine since this amino acid can be fo rmed by
a dditional reactions. In addition, the expected low levels of S- a d e n o s y l m e t h i o n i n e, wh i ch
inhibits methy l e n e t e t ra hy d ro fo l ate re d u c t a s e, might lead to increased fo rm ation of 5-
m e t hy l t e t ra hy d ro fo l at e, thereby ex a c e r b ating the trapping of fo l ates (Surtees et al 1991).
The clear biochemical and haemat o l ogical improvement on high-dose fo l ate tre at m e n t ,
although without clear clinical improvement, has not been rep o rted in other patients with
functional methionine synthase defic i e n cy. Fo l ate tre atment alone has been rep o rted in only
2 other patients. In one with the cblE defect (Schuh et al 1984), no improvement of the
h o m o cy s t i nu ria or mental state was fo u n d. In the other, with the cblG defect and in wh o m
fo rm i m i n oglutamic acid ex c retion was also increased (Shin et al 1986), no re fe rence wa s
made to the sulphur amino acid concentrations, although improved Hb and MCV but not
clinical state we re rep o rt e d. In this latter patient, clinical improvement was rep o rted after
folinic acid tre atment but no obvious decrease in fo rm i m i n oglutamic acid ex c retion wa s
o b s e rve d. In 3 other patients (cblG) fo l ate was used but combined with other tre atment, so
t h at its independent effect cannot be assessed.
In our patient there was a marked clinical improvement on vitamin B1 2 t re atment (Mecbl
in our case) in common with other cblE/G patients, although the MCV remained high.
H oweve r, only on Mecbl combined with fo l ate was there a sustained clinical, bioch e m i c a l
and haemat o l ogical improvement. Other patients may also have benefited from a similar
combined tre atment (Rosenbl att et al 1987; Carmel et al 1988). A study in fib ro bl a s t s
i n d i c ates that methylcobalamin does not dire c t ly increase methionine synthase activ i t y
(Chu et al 1993). Th e re fo re, Mecbl is pro b ably acting after conve rsion to hy d rox o -
cobalamin, as indicated by in vitro studies on the human enzyme (Kolhouse et al 1991), and
l o n ge r- t e rm use of the latter fo rm of B12 m ay also have been effe c t ive in this ch i l d. Th e
findings in this child emphasize the need to consider a wide ra n ge of therapeutic agents in
similar pat i e n t s .
In intact cultured fib ro blasts, synthesis of methionine and serine showed no clear re s p o n s e s
to supplementation of the growth medium with va rious fo rms of fo l at e, singly or combined
with methyl cobalamin. The only in vitro response was a slight increase of methionine and
gre ater increase of serine with cobalamin at the ve ry high concentration of 10mg/L. This is
in contrast to the virtual norm a l i z ation of methionine and serine fo rm ation, in response to
hy d roxocobalamin and methylcobalamin at lower levels of 1mg/L, in cblC/D cells (Fow l e r
et al 1997). The diffe rences between in vivo and in vitro re s p o n s iveness to cofa c t o rs in this
p atient may re flect the complexity of action of methionine synthase as well as the less
p hy s i o l ogical state of the cultured cell system.
Studies of methionine synthase from E. coli, pig liver (Frasca et al 1986; Chen et al 1994)
and human placenta (Utley et al 1985) have indicated a complex mechanism of action of
methionine synthase. In a proposed model (Banerjee and Mat t h ews 1990) there is re d u c t i o n
of the cob(II)alamin fo rm of the enzyme coupled with methy l ation utilizing S-
adenosylmethionine as methyl group donor. The active methy l ated cob(I)alamin fo rm of the
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enzyme donates its methyl group to homocy s t e i n e, fo rming methionine. The demethy l at e d
cob(I)alamin fo rm is either re m e t hy l ated by methy l t e t ra hy d ro fo l ate or ox i d i zed to the
cob(II)alamin fo rm, necessitating a continual re d u c t ive activ i t y.
Th e re fo re, diffe rent mu t ations may affect diffe rent steps in this reaction sequence,
leading to mu ch biochemical and clinical heteroge n e i t y. Similarly, the response to fo l at e
t re atment and increased fo rm i n i m oglutamic acid ex c retion in our patient points to
h e t e rogeneity within the cblE mutant cl a s s .
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